EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,522,318 | -31.7% | 1,035,976 | +47.6% | 0.01% | -30.8% |
| Q2 2023 | $5,159,149 | +6.8% | 701,925 | +50.5% | 0.01% | -7.1% |
| Q1 2023 | $4,831,728 | +87.8% | 466,383 | +114.0% | 0.01% | +75.0% |
| Q4 2022 | $2,573,305 | +395.8% | 217,892 | +1204.3% | 0.01% | +300.0% |
| Q2 2022 | $519,000 | -96.1% | 16,706 | -94.9% | 0.00% | -95.0% |
| Q1 2022 | $13,452,000 | +27.4% | 327,617 | +34.8% | 0.04% | +73.9% |
| Q4 2021 | $10,561,000 | +1522.3% | 242,960 | +1768.9% | 0.02% | +1050.0% |
| Q3 2021 | $651,000 | -97.6% | 13,000 | -97.0% | 0.00% | -96.8% |
| Q2 2021 | $27,656,000 | +10918.3% | 439,055 | +16161.3% | 0.06% | +6200.0% |
| Q1 2021 | $251,000 | -99.1% | 2,700 | -99.0% | 0.00% | -99.0% |
| Q3 2020 | $28,729,000 | +5948.2% | 278,030 | +3288.1% | 0.10% | +2450.0% |
| Q1 2020 | $475,000 | -58.1% | 8,206 | -61.9% | 0.00% | 0.0% |
| Q1 2018 | $1,133,000 | +408.1% | 21,520 | +347.8% | 0.00% | +300.0% |
| Q4 2017 | $223,000 | -88.3% | 4,806 | -91.5% | 0.00% | -85.7% |
| Q2 2017 | $1,907,000 | +23.4% | 56,240 | +14.8% | 0.01% | +16.7% |
| Q3 2016 | $1,545,000 | -62.1% | 49,006 | -66.2% | 0.01% | -64.7% |
| Q2 2016 | $4,076,000 | +43.3% | 144,933 | +85.2% | 0.02% | +21.4% |
| Q1 2016 | $2,845,000 | -66.9% | 78,258 | -63.6% | 0.01% | -65.9% |
| Q4 2015 | $8,605,000 | +221.2% | 215,073 | +128.7% | 0.04% | +192.9% |
| Q3 2015 | $2,679,000 | -42.3% | 94,036 | -33.2% | 0.01% | -36.4% |
| Q2 2015 | $4,642,000 | +23.6% | 140,873 | +7.8% | 0.02% | +15.8% |
| Q1 2015 | $3,757,000 | +62.6% | 130,623 | +53.9% | 0.02% | +46.2% |
| Q4 2014 | $2,311,000 | -62.1% | 84,881 | -64.8% | 0.01% | -60.6% |
| Q1 2014 | $6,101,000 | +204.7% | 241,418 | +177.1% | 0.03% | +200.0% |
| Q4 2013 | $2,002,000 | +149.3% | 87,109 | +106.7% | 0.01% | +120.0% |
| Q3 2013 | $803,000 | -31.2% | 42,143 | -48.0% | 0.01% | -37.5% |
| Q2 2013 | $1,168,000 | – | 81,016 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |